arrow
R

Roderick L. Beijersbergen

Netherlands Cancer Institute
H指数:59
被引数:2.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A genome-wide CRISPR screen in human prostate cancer cells reveals drivers of macrophage-mediated cell killing and positions AR as a tumor-intrinsic immunomodulator

全基因组CRISPR筛选在人前列腺癌细胞中揭示了巨噬细胞介导的细胞杀伤的驱动因子,并将AR定位为肿瘤内源性免疫调节因子

2026-07-280
PRE
DOT1L Shapes ncPRC1-Target Gene Repression to Maintain Germinal Center B-Cell Identity of Diffuse Large B-cell Lymphoma

DOT1L调控ncPRC1靶基因抑制以维持弥漫性大B细胞淋巴瘤的生发中心B细胞特性

Blood
IF23.1
2026-06-020
PRE
Cholesterol biosynthesis as a drug-induced vulnerability in diffuse large B cell lymphoma insensitive to EZH2 inhibition

胆固醇生物合成作为对EZH2抑制不敏感的弥漫性大B细胞淋巴瘤的药物诱导易感靶点

2025-10-270
OAAI
Epigenetic profiling identifies markers of endocrine resistance and therapeutic options for metastatic castration-resistant prostate cancer

表观遗传谱分析鉴定了内分泌抵抗的标志物及转移性去势抵抗性前列腺癌的治疗选择

2025-07-020
OAAI
An antibiotic that mediates immune destruction of senescent cancer cells

一种介导衰老癌细胞免疫破坏的抗生素

2024-12-180
OAAI
Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
2024-03-266
OAAI
Targeting of vulnerabilities of drug-tolerant persisters identified through functional genetics delays tumor relapse
2024-03-018
OAAI
Luminal breast cancer identity is determined by loss of glucocorticoid receptor activity

管腔型乳腺癌的身份取决于糖皮质激素受体活性的丧失

2023-10-305
OAAI
Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1-versus BRCA2-deficient mammary tumors
2023-05-0116
OAAI
PAXIP1 and STAG2 converge to maintain 3D genome architecture and facilitate promoter/enhancer contacts to enable stress hormone-dependent transcription
2023-04-189
OAAI